((RAIN)) Rainmakers-Island

[westeffer]

I wonder if KTOV will have another run after patent news is officially issued next week on their combinational drug for osteo arthritis and high BP? They will supposedly enjoy exclusivity up to 20 years with an extension due to length of issue. NDA filing coming by 4th quarter and supposed sales release by FDA in 2017 since these drugs are already approved as separate filings by the FDA. It is a huge market where Celebrex generic does great but has black box issues for sales and KTOV combinational drug eliminates the cardiovascular concerns from taking Celebrex alone or with other BP drugs as separate treatments.

It is a huge market and the patent will certainly be worth serious money. Meanwhile they would have about 15,250,000 shares fully diluted and $20 million in cash and no debt. I have been buying warrants KTOVW down here after recent run and retreat to current levels after raising funds.